241 related articles for article (PubMed ID: 28730269)
21. Biofilms and vulvovaginal candidiasis.
Rodríguez-Cerdeira C; Gregorio MC; Molares-Vila A; López-Barcenas A; Fabbrocini G; Bardhi B; Sinani A; Sánchez-Blanco E; Arenas-Guzmán R; Hernandez-Castro R
Colloids Surf B Biointerfaces; 2019 Feb; 174():110-125. PubMed ID: 30447520
[TBL] [Abstract][Full Text] [Related]
22. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
Adjapong G; Hale M; Garrill A
Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
[TBL] [Abstract][Full Text] [Related]
23. Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern.
Fernandes Â; Azevedo N; Valente A; Dias M; Gomes A; Nogueira-Silva C; Henriques M; Silva S; Gonçalves B
Med Mycol; 2022 May; 60(5):. PubMed ID: 35482711
[TBL] [Abstract][Full Text] [Related]
24. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
25. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
26. Antifungal efficacy of propolis against fluconazole-resistant Candida glabrata isolates obtained from women with recurrent vulvovaginal candidiasis.
Shokri H; Khosravi AR; Yalfani R
Int J Gynaecol Obstet; 2011 Aug; 114(2):158-9. PubMed ID: 21669419
[No Abstract] [Full Text] [Related]
27. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
Fan SR; Liu XP; Li JW
J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
[TBL] [Abstract][Full Text] [Related]
29. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
30. Candida species isolated from the vaginal mucosa of HIV-infected women in Salvador, Bahia, Brazil.
Oliveira PM; Mascarenhas RE; Lacroix C; Ferrer SR; Oliveira RP; Cravo EA; Alves AP; Grassi MF
Braz J Infect Dis; 2011; 15(3):239-44. PubMed ID: 21670924
[TBL] [Abstract][Full Text] [Related]
31. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
32. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
33. Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
Wang FJ; Zhang D; Liu ZH; Wu WX; Bai HH; Dong HY
Chin Med J (Engl); 2016 May; 129(10):1161-5. PubMed ID: 27174323
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of overtime phenotypic variation of yeasts in chronic vulvovaginal candidosis cases.
Faria-Gonçalves P; Gaspar C; Oliveira AS; Palmeira-de-Oliveira R; Gonçalves T; Martinez-de-Oliveira J; Palmeira-de-Oliveira A; Rolo J
Med Mycol; 2021 Dec; 59(12):1166-1173. PubMed ID: 34427667
[TBL] [Abstract][Full Text] [Related]
35. Changing virulence factors among vaginal non-
Kalaiarasan K; Singh R; Chaturvedula L
Indian J Med Microbiol; 2018; 36(3):364-368. PubMed ID: 30429388
[TBL] [Abstract][Full Text] [Related]
36. Differential Response of
Salama OE; Gerstein AC
Antimicrob Agents Chemother; 2022 May; 66(5):e0240621. PubMed ID: 35446135
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
Mushi MF; Olum R; Bongomin F
Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514
[TBL] [Abstract][Full Text] [Related]
38. Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics.
Paiva LC; Vidigal PG; Donatti L; Svidzinski TI; Consolaro ME
Micron; 2012 Feb; 43(2-3):497-502. PubMed ID: 22001373
[TBL] [Abstract][Full Text] [Related]
39. Effect of the Pulsatilla decoction n-butanol extract on vulvovaginal candidiasis caused by Candida glabrata and on its virulence factors.
Zhang J; Jiang X; Shi G; Zhang H; Hu K; Wu D; Shao J; Liu T; Wang T; Wang C
Fitoterapia; 2024 Mar; 173():105825. PubMed ID: 38219843
[TBL] [Abstract][Full Text] [Related]
40. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression.
Zhang JY; Liu JH; Liu FD; Xia YH; Wang J; Liu X; Zhang ZQ; Zhu N; Yan-Yan ; Ying Y; Huang XT
Mycoses; 2014 Oct; 57(10):584-91. PubMed ID: 24962255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
